Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Viking Therapeutics (VKTX) Shares Outstanding (2016 - 2026)

Viking Therapeutics (VKTX) has disclosed Shares Outstanding for 13 consecutive years, with $115.9 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding rose 3.21% year-over-year to $115.9 million; the TTM value through Mar 2026 reached $115.9 million, up 3.21%, while the annual FY2025 figure was $114.8 million, 2.89% up from the prior year.
  • Shares Outstanding hit $115.9 million in Q1 2026 for Viking Therapeutics, up from $114.8 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $115.9 million in Q1 2026 and bottomed at $76.7 million in Q2 2022.
  • Average Shares Outstanding over 5 years is $100.0 million, with a median of $110.2 million recorded in 2024.
  • Year-over-year, Shares Outstanding dropped 1.98% in 2022 and then skyrocketed 38.97% in 2024.
  • Viking Therapeutics' Shares Outstanding stood at $78.3 million in 2022, then rose by 27.93% to $100.1 million in 2023, then increased by 11.45% to $111.6 million in 2024, then grew by 2.89% to $114.8 million in 2025, then increased by 0.96% to $115.9 million in 2026.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $115.9 million, $114.8 million, and $112.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.